Navigation Links
China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification
Date:9/19/2008

ments within the EU."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio- Engineering Company Limited, and Heilongjiang Tianlong Pharmaceutical, Inc., the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

Comp
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
2. China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
3. China Biopharma Effects 1 for 100 Reverse Stock Split
4. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
5. China Yingxia International, Inc. Appoints New Vice President of Finance
6. China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility
7. China Biologic Products to Present at the SIG Beijing Management Summit
8. China Biologics Production Facility Renews GMP Certification
9. China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit
10. Plexus Announces Expansion in Hangzhou, China
11. China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Invetech ... development, custom automation, and contract manufacturing, and  NanoCellect ... flow cytometry and cell sorting technology for life ... a novel flow cytometry platform. Headquartered ... Biomedical has developed a microchip-based cell sorting technology. ...
(Date:4/21/2015)... , April 21, 2015  scPharmaceuticals, Inc., ... pharmaceutical products for subcutaneous delivery, announced today ... of its investigational proprietary drug product, Furosemide ... associated with congestive heart failure. ... developing a proprietary patch pump.  The patch ...
(Date:4/21/2015)... Cleveleys (UK) (PRWEB) April 21, 2015 ... technology and its clinical applications will be ... Participants include engineers, scientists, regulators and clinicians ... The meeting is sponsored by Invibio Biomaterial ... polymer-based biomaterials, a specialist in manufacturing and ...
(Date:4/20/2015)... and MENLO PARK, Calif. ... Inc. (OTCQX: DMPI) (DelMar and the Company), ... proven cancer therapies in new orphan drug indications, ... 106th Annual Meeting of the American Association for ... potential for its lead product candidate VAL-083 ...
Breaking Biology Technology:NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 2NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 3scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 32nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5
... will hold the $14 million clinical training programs administrative ... of Wisconsin-Madison intends to train more clinical researchers, whose ... science, with the help of a $14 million, five-year ... , ,Molly Carnes, a professor with appointments in the ...
... UW-Stout gets USDA grant for manufacturing training ETC announces ... in third quarter QRG Bioscience to move to Research ... , Home Health United signs deal with SBC ... a three-year deal with communications firm SBC . SBC will implement ...
... 21st Century Act, commonly called Check 21, two Wisconsin ... imaging. , ,Check 21, which will come into effect ... of the payments system by legalizing the use of ... documents. Using the substitute check, banks are permitted to ...
Cached Biology Technology:$14 million grant to drive clinical research at UW 2Tech Digest: whats moving in the Midwest 2Tech Digest: whats moving in the Midwest 3Wisconsin firms make acquisitions for Check 21 readiness 2
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... are often touted as one method to help decrease society,s addiction ... to be done before fuel cells will be ready for mass ... for emergencies. U of C chemists Jeff Hurd and George ... cell towards a higher level of design. They have discovered a ...
... Scientists are developing new scaffolding technology which could ... and cartilage using 3D spaghetti-like structures. Their research is ... highlights magazine of the Biotechnology and Biological Sciences Research ... by scientists from the University of Bristol, using proteins ...
... clinical-stage biopharmaceutical company developing a new class of drugs ... data from its recently completed Phase 2b clinical trial ... with major depressive disorder, or MDD, who did not ... citalopram hydrobromide. In the trial, the add-on TC-5214 ...
Cached Biology News:U of C chemists discover recipe to design a better type of fuel cell 2'Spaghetti' scaffolding could help grow skin in labs 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 3
... AP Conjugate Stabilizer is an aqueous ... protein and other non-toxic stabilizing chemicals ... pH 5.5 6.5. This ... methylisothiazolone and 0.02% bromonitrodioxane as a ...
MAb to Myoglobin Cardiac...
... binding is a problem in your ... immobilized NeutrAvidin products as superior alternatives ... a modified avidin derivative that combines ... biotin-binding protein with exceptionally low nonspecific ...
Request Info...
Biology Products: